More about
Recurrent Vascular Access Thrombosis
News
November 04, 2023
1 min read
Save
Lower rates of access thrombosis for patients with CKD who receive daprodustat vs. EPO
PHILADELPHIA — Patients with chronic kidney disease on dialysis who received daprodustat had fewer vascular access thrombosis events compared with patients who had erythropoiesis-stimulating agents, according to data presented here.